
TVTX
Healthcare · Biotechnology · $4.86B market cap
$50.65-0.91 (-1.8%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -29.7% over 90 days · 30-day revisions 1 up, 3 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 2, 2026 | After the close | -0.25 | -0.55 | -120.0% |
| Aug 4, 2026 | After the close | -0.14 | -0.37 | -164.3% |
| May 4, 2026 | After the close | -0.06 | 0.05 | +183.3% |
| Feb 19, 2026 | Time not confirmed | -0.04 | 0.37 | +1025.0% |
| Oct 30, 2025 | After the close | -0.08 | 0.59 | +837.5% |
| Aug 6, 2025 | After the close | 0.04 | 0.13 | +225.0% |
| May 1, 2025 | After the close | -0.39 | -0.19 | +51.3% |
| Feb 13, 2025 | Before the open | -0.38 | -0.47 | -24.1% |
| Oct 31, 2024 | Before the open | -0.54 | -0.46 | +14.8% |
| Aug 1, 2024 | After the close | -0.72 | -0.65 | +9.7% |
| May 6, 2024 | After the close | -0.79 | -1.51 | -91.1% |
| Feb 15, 2024 | After the close | -0.92 | -0.94 | -2.2% |
| Nov 7, 2023 | After the close | 0.04 |
Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States. The company's products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC…
| 2.27 |
| +5575.0% |
| Aug 3, 2023 | After the close | -0.93 | -0.77 | +17.2% |
| May 4, 2023 | After the close | -1.03 | -0.82 | +20.4% |
| Feb 23, 2023 | After the close | -1.07 | -1.03 | +3.7% |
| Oct 27, 2022 | After the close | -0.70 | -0.76 | -8.6% |
| Aug 4, 2022 | Before the open | -0.70 | -0.65 | +7.1% |
| May 5, 2022 | After the close | -0.73 | -0.82 | -12.3% |
| Feb 24, 2022 | After the close | -0.50 | -0.61 | -22.0% |
| Oct 28, 2021 | After the close | -0.48 | -0.13 | +72.9% |
| Jul 29, 2021 | After the close | -0.50 | -0.39 | +22.0% |
| May 6, 2021 | After the close | -0.30 | -0.55 | -83.3% |
| Mar 1, 2021 | After the close | -0.47 | -0.48 | -2.1% |
| Nov 5, 2020 | After the close | -0.29 | -0.11 | +62.1% |
| Jul 30, 2020 | After the close | -0.36 | -0.22 | +38.9% |
| May 11, 2020 | After the close | -0.52 | -0.20 | +61.5% |
| Feb 24, 2020 | After the close | -0.37 | -0.26 | +29.7% |
| Oct 30, 2019 | After the close | -0.60 | -0.66 | -10.0% |
| Aug 6, 2019 | After the close | -0.40 | -0.58 | -45.0% |
| May 7, 2019 | After the close | -0.36 | -0.63 | -75.0% |
| Feb 26, 2019 | After the close | -0.48 | -0.18 | +62.5% |
| Nov 1, 2018 | After the close | -0.26 | -0.68 | -161.5% |
| Jul 26, 2018 | After the close | -0.11 | -0.25 | -127.3% |
| May 1, 2018 | After the close | -0.36 | -0.14 | +61.1% |
| Feb 27, 2018 | After the close | -0.19 | -0.45 | -136.8% |